Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 8781379, 7 pages
https://doi.org/10.1155/2017/8781379
Research Article

Validation of a Machine Learning Approach for Venous Thromboembolism Risk Prediction in Oncology

1Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, 00166 Rome, Italy
2Interinstitutional Multidisciplinary Biobank (BioBIM), IRCCS San Raffaele Pisana, 00166 Rome, Italy
3Department of Enterprise Engineering, University of Rome “Tor Vergata”, 00133 Rome, Italy
4Department of Systems Medicine, Medical Oncology, University of Rome “Tor Vergata”, 00133 Rome, Italy

Correspondence should be addressed to Fiorella Guadagni

Received 13 June 2017; Accepted 30 July 2017; Published 17 September 2017

Academic Editor: Dennis W. T. Nilsen

Copyright © 2017 Patrizia Ferroni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Y. Wu, C. W. Cheng, C. Kaddi, J. Venugopalan, R. Hoffman, and M. D. Wang, “Advanced big data analytics for -omic data and electronic health records: toward precision medicine,” IEEE Transactions on Biomedical Engineering, 2016. View at Publisher · View at Google Scholar
  2. July 2017, https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative.
  3. H. A. Liebman, A. A. Khorana, and C. M. Kessler, “Clinical roundtable monograph: the oncologist’s role in the management of venous thromboembolism,” Clinical Advances in Hematology & Oncology, vol. 9, pp. 1–15, 2011. View at Google Scholar
  4. G. H. Lyman, K. Bohlke, A. A. Khorana et al., “Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014,” Journal of Clinical Oncology, vol. 33, pp. 654–656, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Khorana, H. M. Otten, J. I. Zwicker et al., “Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH,” Journal of Thrombosis and Haemostasis, vol. 12, pp. 1928–1931, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. A. Khorana, N. M. Kuderer, E. Culakova, G. H. Lyman, and C. W. Francis, “Development and validation of a predictive model for chemotherapy-associated thrombosis,” Blood, vol. 111, pp. 4902–4907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Ay, D. Dunkler, C. Marosi et al., “Prediction of venous thromboembolism in cancer patients,” Blood, vol. 116, pp. 5377–5382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Abdel-Razeq, A. Mansour, S. S. Saadeh et al., “The application of current proposed venous thromboembolism risk assessment model for ambulatory patients with cancer,” Clinical and Applied Thrombosis/Hemostasis, 2017. View at Publisher · View at Google Scholar
  9. A. S. Mansfield, A. J. Tafur, C. E. Wang, T. V. Kourelis, E. M. Wysokinska, and P. Yang, “Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer,” Journal of Thrombosis and Haemostasis, vol. 14, pp. 1773–1778, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. R. C. Deo, “Machine learning in medicine,” Circulation, vol. 132, pp. 1920–1930, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Ferroni, F. M. Zanzotto, N. Scarpato et al., “Risk assessment for venous thromboembolism in chemotherapy-treated ambulatory cancer patients: a machine learning approach,” Medical Decision Making, vol. 37, pp. 234–242, 2017. View at Publisher · View at Google Scholar
  12. M. Roselli, P. Ferroni, S. Riondino et al., “Impact of chemotherapy on activated protein C-dependent thrombin generation—association with VTE occurrence,” International Journal of Cancer, vol. 133, pp. 1253–1258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Ferroni, M. Roselli, S. Riondino, and F. Guadagni, “Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy,” Journal of Thrombosis and Haemostasis, vol. 12, pp. 2049–2053, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Ferroni, S. Riondino, F. Guadagni, and M. Roselli, “Insulin resistance and risk of venous thromboembolism in breast cancer,” Endocrine Related Cancer, vol. 23, pp. L25–L28, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Ferroni, F. Guadagni, A. Laudisi et al., “Estimated GFR is an independent predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy,” The Oncologist, vol. 19, pp. 562–567, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Saar-Tsechansky and F. Provost, “Handling missing values when applying classification models,” Journal of Machine Learning Research, vol. 8, pp. 1623–1657, 2007. View at Google Scholar
  17. A. Srikanthan, B. Tran, M. Beausoleil et al., “Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy,” Journal of Clinical Oncology, vol. 33, pp. 582–587, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. J. D. Ramos, M. F. Casey, A. Bamias et al., “The Khorana score in predicting venous thromboembolism for patients with metastatic urothelial carcinoma and variant histology treated with chemotherapy,” Clinical and Applied Thrombosis/Hemostasis, 2016. View at Publisher · View at Google Scholar
  19. Y. G. Lee, E. Lee, I. Kim et al., “Cisplatin-based chemotherapy is a strong risk factor for thromboembolic events in small-cell lung cancer,” Cancer Research and Treatment, vol. 47, pp. 670–675, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Alexander and K. Burbury, “A systematic review of biomarkers for the prediction of thromboembolism in lung cancer—results, practical issues and proposed strategies for future risk prediction models,” Thrombosis Research, vol. 148, pp. 63–69, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. N. van Es, V. F. Franke, S. Middeldorp, J. W. Wilmink, and H. R. Büller, “The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer,” Thrombosis Research, vol. 150, pp. 30–32, 2017. View at Publisher · View at Google Scholar
  22. M. Vergati, D. Della Morte, P. Ferroni et al., “Increased risk of chemotherapy-associated venous thromboembolism in elderly patients with cancer,” Rejuvenation Research, vol. 16, pp. 224–231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Verso, G. Agnelli, S. Barni, G. Gasparini, and R. LaBianca, “A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score,” Internal and Emergency Medicine, vol. 7, pp. 291-292, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Jin, B. W. Wah, X. Cheng, and Y. Wang, “Significance and challenges of big data research,” Big Data Research, vol. 2, pp. 59–64, 2015. View at Google Scholar